Tau accelerates α-synuclein aggregation and spreading in Parkinson’s disease

Lina Pan,Chunrui Li,Lanxia Meng,Ye Tian,Mingyang He,Xin Yuan,Guoxin Zhang,Zhaohui Zhang,Jing Xiong,Guiqin Chen,Zhentao Zhang
DOI: https://doi.org/10.1093/brain/awac171
IF: 14.5
2022-01-01
Brain
Abstract:Abstract The aggregation and prion-like propagation of α-synuclein are involved in the pathogenesis of Parkinson’s disease. However, the underlying mechanisms regulating the assembly and spreading of α-synuclein fibrils remain poorly understood. Tau co-deposits with α-synuclein in the brains of Parkinson’s disease patients, suggesting a pathological interplay between them. Here we show that tau interacts with α-synuclein and accelerates its aggregation. Compared with pure α-synuclein fibrils, the tau-modified α-synuclein fibrils show enhanced seeding activity, inducing mitochondrial dysfunction, synaptic impairment and neurotoxicity in vitro. Injection of the tau-modified α-synuclein fibrils into the striatum of mice induces more severe α-synuclein pathology, motor dysfunction and cognitive impairment when compared with the mice injected with pure α-synuclein fibrils. Knockout of tau attenuates the propagation of α-synuclein pathology and Parkinson’s disease-like symptoms both in mice injected with α-syn fibrils and α-syn A53T transgenic mice. In conclusion, tau facilitates α-synuclein aggregation and propagation in Parkinson’s disease.
What problem does this paper attempt to address?